Works matching DE "HERPES zoster vaccines"
Results: 771
Expanding the coverage of herpes zoster vaccination recommendations in European countries: the example of Portugal: Expanding the coverage of herpes zoster vaccination recommendations in Europe: S. Duque et al.
- Published in:
- Drugs & Therapy Perspectives, 2025, v. 41, n. 1, p. 34, doi. 10.1007/s40267-024-01126-0
- By:
- Publication type:
- Article
Models for optimally controlling varicella and herpes zoster by varicella vaccination: a comparative study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cost-Effectiveness of the Screening for the Primary Prevention of Fragility Hip Fracture in Spain Using FRAX<sup>®</sup>.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Recognizing Occult Immunosuppression in Primary Care.
- Published in:
- Family Doctor: A Journal of the New York State Academy of Family Physicians, 2022, v. 11, n. 2, p. 30
- By:
- Publication type:
- Article
Recent Updates on the ACIP Vaccine Recommendations.
- Published in:
- Family Doctor: A Journal of the New York State Academy of Family Physicians, 2022, v. 11, n. 2, p. 13
- By:
- Publication type:
- Article
Herpes zoster vaccination: An update.
- Published in:
- Medicine Today, 2024, v. 25, n. 6, p. 51
- By:
- Publication type:
- Article
Autoimmune inflammatory rheumatic diseases: Vaccines are important.
- Published in:
- Medicine Today, 2024, v. 25, n. 4, p. 53
- By:
- Publication type:
- Article
Anti-Inflammatory Activity of Glyceryl 1,3-Distearate Identified from Clinacanthus nutans Extract against Bovine Mastitis Pathogens.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 3, p. 549, doi. 10.3390/antibiotics12030549
- By:
- Publication type:
- Article
Development and Evaluation of the Immunogenic Potential of an Unmodified Nucleoside mRNA Vaccine for Herpes Zoster.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 68, doi. 10.3390/vaccines13010068
- By:
- Publication type:
- Article
Post-Vaccination Anaphylaxis in Adults: A Systematic Review and Meta-Analysis.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 37, doi. 10.3390/vaccines13010037
- By:
- Publication type:
- Article
Vaccinating in Different Settings: Best Practices from Italian Regions.
- Published in:
- Vaccines, 2025, v. 13, n. 1, p. 16, doi. 10.3390/vaccines13010016
- By:
- Publication type:
- Article
Challenges and Opportunities for Adult Vaccine Coverage: Insights for Healthcare Professionals Focusing on Herpes Zoster in Mexico.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1441, doi. 10.3390/vaccines12121441
- By:
- Publication type:
- Article
The Herpes Zoster Patient Pathway and Gaps in Current Vaccination Guidelines in Southeast Asia: Summary of a Zoster Experts' Network Scientific Workshop.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1433, doi. 10.3390/vaccines12121433
- By:
- Publication type:
- Article
Post-Marketing Surveillance of Adverse Events for the Recombinant Zoster Vaccine Among the Population over 50 Years Old in Hangzhou, China.
- Published in:
- Vaccines, 2024, v. 12, n. 12, p. 1376, doi. 10.3390/vaccines12121376
- By:
- Publication type:
- Article
Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma.
- Published in:
- Vaccines, 2024, v. 12, n. 11, p. 1216, doi. 10.3390/vaccines12111216
- By:
- Publication type:
- Article
Truncated VZV gE Induces High-Titer Neutralizing Antibodies in Mice.
- Published in:
- Vaccines, 2024, v. 12, n. 10, p. 1139, doi. 10.3390/vaccines12101139
- By:
- Publication type:
- Article
Immunity to Varicella Zoster Virus in Healthcare Workers: A Systematic Review and Meta-Analysis (2024).
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 1021, doi. 10.3390/vaccines12091021
- By:
- Publication type:
- Article
Safety of Adjuvanted Recombinant Herpes Zoster Virus Vaccination in Fragile Populations: An Observational Real-Life Study.
- Published in:
- Vaccines, 2024, v. 12, n. 9, p. 990, doi. 10.3390/vaccines12090990
- By:
- Publication type:
- Article
The Influence of Altitude, Urbanization, and Local Vaccination Centers on Vaccine Uptake within an Italian Health District: An Analysis of 15,000 Individuals Eligible for Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 875, doi. 10.3390/vaccines12080875
- By:
- Publication type:
- Article
Cost-Effectiveness Analysis of Herpes Zoster Vaccination in a Chinese Population: Recombinant Subunit Vaccine versus Live Attenuated Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 8, p. 872, doi. 10.3390/vaccines12080872
- By:
- Publication type:
- Article
Comparison of the Immunogenicity of the LZ901 Vaccine and HZ/su Vaccine in a Mouse Model.
- Published in:
- Vaccines, 2024, v. 12, n. 7, p. 775, doi. 10.3390/vaccines12070775
- By:
- Publication type:
- Article
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 527, doi. 10.3390/vaccines12050527
- By:
- Publication type:
- Article
Anti-Herpes Zoster Vaccination of Fragile Patients in Hospital Setting: A Nudge Intervention in Italy.
- Published in:
- Vaccines, 2024, v. 12, n. 4, p. 442, doi. 10.3390/vaccines12040442
- By:
- Publication type:
- Article
Herpes Zoster and Cardiovascular Disease: Exploring Associations and Preventive Measures through Vaccination.
- Published in:
- Vaccines, 2024, v. 12, n. 3, p. 252, doi. 10.3390/vaccines12030252
- By:
- Publication type:
- Article
Transcriptomic Analysis Reveals Sixteen Potential Genes Associated with the Successful Differentiation of Antibody-Secreting Cells through the Utilization of Unfolded Protein Response Mechanisms in Robust Responders to the Influenza Vaccine.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 136, doi. 10.3390/vaccines12020136
- By:
- Publication type:
- Article
Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 51, doi. 10.3390/vaccines12010051
- By:
- Publication type:
- Article
Quantitative Synthesis of Factors Associated with COVID-19 Vaccine Acceptance and Vaccine Hesitancy in 185 Countries.
- Published in:
- Vaccines, 2024, v. 12, n. 1, p. 34, doi. 10.3390/vaccines12010034
- By:
- Publication type:
- Article
Pre-Clinical Development of an Adenovirus Vector Based RSV and Shingles Vaccine Candidate.
- Published in:
- Vaccines, 2023, v. 11, n. 11, p. 1679, doi. 10.3390/vaccines11111679
- By:
- Publication type:
- Article
The Real-World Study of Immunogenicity and Safety of the Adjuvant Recombinant Vaccine against Varicella Zoster Virus in Patients with Immune-Mediated Inflammatory Diseases Treated with Janus Kinase Inhibitors.
- Published in:
- Vaccines, 2023, v. 11, n. 10, p. 1610, doi. 10.3390/vaccines11101610
- By:
- Publication type:
- Article
Use of Information and Communication Technology Strategies to Increase Vaccination Coverage in Older Adults: A Systematic Review.
- Published in:
- Vaccines, 2023, v. 11, n. 7, p. 1274, doi. 10.3390/vaccines11071274
- By:
- Publication type:
- Article
Comparison of the Immune Effects of an mRNA Vaccine and a Subunit Vaccine against Herpes Zoster Administered by Different Injection Methods.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 1003, doi. 10.3390/vaccines11051003
- By:
- Publication type:
- Article
Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III).
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 998, doi. 10.3390/vaccines11050998
- By:
- Publication type:
- Article
Surveying a Sample of the Spanish Ophthalmologic Community about Vaccination against Herpes Zoster.
- Published in:
- Vaccines, 2023, v. 11, n. 5, p. 952, doi. 10.3390/vaccines11050952
- By:
- Publication type:
- Article
Views and Perceptions of People Aged 55+ on the Vaccination Programme for Older Adults in the UK: A Qualitative Study.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 870, doi. 10.3390/vaccines11040870
- By:
- Publication type:
- Article
Influenza, Pneumococcal and Herpes Zoster Vaccination Rates in Patients with Autoimmune Inflammatory Rheumatic Diseases.
- Published in:
- Vaccines, 2023, v. 11, n. 4, p. 760, doi. 10.3390/vaccines11040760
- By:
- Publication type:
- Article
Acceptability of Herpes Zoster Vaccination among Patients with Diabetes: A Cross-Sectional Study in Saudi Arabia.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 651, doi. 10.3390/vaccines11030651
- By:
- Publication type:
- Article
Immunogenicity and Safety of the Third Booster Dose with mRNA-1273 COVID-19 Vaccine after Receiving Two Doses of Inactivated or Viral Vector COVID-19 Vaccine.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 553, doi. 10.3390/vaccines11030553
- By:
- Publication type:
- Article
Truncation of NS1 Protein Enhances T Cell-Mediated Cross-Protection of a Live Attenuated Influenza Vaccine Virus Expressing Wild-Type Nucleoprotein.
- Published in:
- Vaccines, 2023, v. 11, n. 3, p. 501, doi. 10.3390/vaccines11030501
- By:
- Publication type:
- Article
Death and Disability Reported with Cases of Vaccine Anaphylaxis Stratified by Administration Setting: An Analysis of the Vaccine Adverse Event Reporting System from 2017 to 2022.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 276, doi. 10.3390/vaccines11020276
- By:
- Publication type:
- Article
Immunoinformatics Approaches for Vaccine Design: A Fast and Secure Strategy for Successful Vaccine Development.
- Published in:
- Vaccines, 2023, v. 11, n. 2, p. 221, doi. 10.3390/vaccines11020221
- By:
- Publication type:
- Article
The Effect of the COVID-19 Pandemic on Vaccination Behaviour of Individuals over the Age of 65 Years in Turkey: Single-Centre Experience.
- Published in:
- Vaccines, 2023, v. 11, n. 1, p. 34, doi. 10.3390/vaccines11010034
- By:
- Publication type:
- Article
Novel BC02 Compound Adjuvant Enhances Adaptive and Innate Immunity Induced by Recombinant Glycoprotein E of Varicella-Zoster Virus.
- Published in:
- Vaccines, 2022, v. 10, n. 12, p. 2155, doi. 10.3390/vaccines10122155
- By:
- Publication type:
- Article
Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice.
- Published in:
- Vaccines, 2022, v. 10, n. 8, p. 1339, doi. 10.3390/vaccines10081339
- By:
- Publication type:
- Article
Prospective, Longitudinal Study on Specific Cellular Immune Responses after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Kidney Transplant Recipients.
- Published in:
- Vaccines, 2022, v. 10, n. 6, p. N.PAG, doi. 10.3390/vaccines10060844
- By:
- Publication type:
- Article
Cellular Immune Response after Vaccination with an Adjuvanted, Recombinant Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
- Published in:
- Vaccines, 2022, v. 10, n. 5, p. 809, doi. 10.3390/vaccines10050809
- By:
- Publication type:
- Article
Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant.
- Published in:
- Vaccines, 2022, v. 10, n. 4, p. N.PAG, doi. 10.3390/vaccines10040529
- By:
- Publication type:
- Article
The Association of Previous Vaccination with Live-Attenuated Varicella Zoster Vaccine and COVID-19 Positivity: An Israeli Population-Based Study.
- Published in:
- Vaccines, 2022, v. 10, n. 1, p. 74, doi. 10.3390/vaccines10010074
- By:
- Publication type:
- Article
Effects of Varicella-Zoster Virus Glycoprotein E Carboxyl-Terminal Mutation on mRNA Vaccine Efficacy.
- Published in:
- Vaccines, 2021, v. 9, n. 12, p. 1440, doi. 10.3390/vaccines9121440
- By:
- Publication type:
- Article
Risk Factors for Herpes Zoster in Patients with Chronic Kidney Disease: A Case-Control Study.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays.
- Published in:
- Vaccines, 2021, v. 9, n. 8, p. 875, doi. 10.3390/vaccines9080875
- By:
- Publication type:
- Article